Steven Reichling, Chief Financial Officer at Accelerate Diagnostics, Inc (AXDX), sold 859 shares at $7.37 ($6K) on 2020-12-17, disclosed to the SEC on 2021-02-03.
Open-market sale of $6k AXDX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| AXDX | SELL | 2023-02-15 | $3K | — | Filing → |
| AXDX | SELL | 2023-01-17 | $3K | — | Filing → |
| AXDX | BUY | 2022-08-22 | $7K | — | Filing → |